6 Best Terpenes for Pain and Inflammation Relief
by Olivia Swann
The National Institute of Standards and Technology, or NIST, for short, will be conducting a study on obtaining accurate and precise measurements to distinguish the difference “between hemp and marijuana.” That statement alone stresses the need for a universal language to be adopted when addressing the cannabis industry. What NIST should be studying is how to accurately determine hemp from medical or retail cannabis.
The NIST study being conducted is part of the Cannabis Quality Assurance Program or CannaQAP. This program was implemented to help the forensic and cannabis industry learn more efficient methods for precisely measuring cannabinoids. NIST may want to start their study by heading to Ohio. The state of Ohio previously spent nearly a million dollars on a machine that was supposed to be able to quickly and accurately do just this. It seems like a waste of a million dollars to develop such a machine in the state of Ohio though they can probably make that money back on just a few arrests.
Currently, THC levels must be at 0.3% or less in the United States for cannabis to be considered hemp. This personally throws me in a big confusion. The labs that test the strength of cannabis or the levels of cannabinoids have a variant difference that goes up or down. It usually ranges around 10% in either direction. This means a strain that tests 20% THC might only have 10%, or it might have 30%, but it’s a safe bet to say it has around 20%. No wonder they have a hard time determining 0.3% THC.
One of the benefits of this study would be to allow labs to more accurately test for levels of cannabinoids. NIST made it clear they are not looking to undermine the ability of a lab to produce quality and accurate results. Instead, they are looking to provide a learning opportunity so that laboratories can become more efficient and use validated methods to obtain specific and precise measurements of cannabinoids.
Knowledge like this could greatly benefit many different people. The United States is currently in a state of confusion when it comes to cannabis legalization as hemp is legal to produce everywhere and medical or retail cannabis is not. If someone is suspected of growing retail or medical cannabis in a location they are not permitted to, and legal actions are taken, law enforcement needs to be positive they are acting appropriately. If you raid a hemp farmer’s house claiming they’re growing psychoactive cannabis, you might find yourself having a lawsuit against you.
In 2014, media reports indicated that police in Georgia actually raided an okra farmer’s house, believing he was growing the devil’s lettuce. That’s how easy it is for law enforcement to mistake cannabis. Imagine not being able to tell the difference between okra or a bud. As you can see, law enforcement needs all the help they can when it comes to identifying the difference between hemp and medical or retail cannabis.
Cannabis legalization is a beautiful thing. It is great to see people have access to this plant. Just the same, it is sad to see people still don’t have access to this plant. The prohibition of this widely misunderstood plant was built on a foundation of lies and falsehoods. It’s time to acknowledge the ways of the past were wrong and start correcting them.
Continuing to figure out ways to prosecute people for cannabis seems to be clinging to the past. Perhaps we should move forward and figure out how to settle this issue once and for all. Cannabis isn’t harming people. Those who support its overregulation and continued prohibition are.
It will be interesting to see what NIST concludes in their study. Especially how it may lay the groundwork for more precise accuracy in regard to cannabinoid testing in the future months and years to come as this plant finds its way back into legality around the world.
Cannabis’ former reputation as a gateway drug may have been dispelled, but it turns out that there is some element of truth to the rumor: The plant’s progressively evolving status as a normalized medicine in 37 U.S. states and a recreational substance in 18 U.S. states is prompting a wave of change across America’s statehouses….
Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa. Nicknamed “K,” “special K,” “cat valium,” and “vitamin K,” ketamine is…
The worldwide skincare industry, which is projected to inflate to $189.3 billion USD by 2025, could soon be merging more closely with cannabis. In particular, the cannabis plant’s non-intoxicating compound cannabidiol (CBD) is grasping the attention of experts in this field of work for its ability to amplify the effects of retinol. Retinol, a fat-soluble…
Austin decriminalized cannabis possession, Vancouver is now home to some not-so-legal magic mushroom shops, and a British woman shared her life-changing medical marijuana journey. Let’s dive into this week’s cannanews. Austin Voters Pass Cannabis Decriminalization Bill Voters in Austin, Texas, have approved Proposition A, a ballot measure that decriminalizes cannabis possession and bans no-knock warrants….
As if losing a limb is not hard enough, experiencing pain in the part of the limb that is no longer there acts as a constant reminder of what has been lost on top of the actual pain. Phantom limb pain (PLP) plagues an estimated 8 out of 10 people who have lost a limb,…
Research reveals that cannabis can impact male reproductive health through reprogramming sperm, which may have implications for any baby born from such…
Woody Harrelson’s new dispensary opened for business, Thailand announced its giveaway of 1 million cannabis plants, and Vermont awarded its first cannabis…
There’s no denying the fact that CBD is dominating the wellness landscape. Increasing awareness of the cannabinoid’s medicinal effects is going hand-in-hand…